Cardiovascular risk in pediatric-onset rheumatological diseases
Open Access
- 22 May 2013
- journal article
- review article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 15 (3) , 1-12
Abstract
Cardiovascular morbidity and mortality are becoming major health concerns for adults with inflammatory rheumatic diseases. The enhanced atherogenesis in this patient population is promoted by the exposure to traditional risk factors as well as nontraditional cardiovascular insults, such as corticosteroid therapy, chronic inflammation and autoantibodies. Despite definite differences between many adult-onset and pediatric-onset rheumatologic diseases, it is extremely likely that atherosclerosis will become the leading cause of morbidity and mortality in this pediatric patient population. Because cardiovascular events are rare at this young age, surrogate measures of atherosclerosis must be used. The three major noninvasive vascular measures of early atherosclerosis - namely, flow-mediated dilatation, carotid intima-media thickness and pulse wave velocity - can be performed easily on children. Few studies have explored the prevalence of cardiovascular risk factors and even fewer have used the surrogate vascular measures to document signs of early atherosclerosis in children with pediatric-onset rheumatic diseases. The objective of this review is to provide an overview on cardiovascular risk and early atherosclerosis in pediatric-onset systemic lupus erythematosus, juvenile idiopathic arthritis and juvenile dermatomyositis patients, and to review cardiovascular preventive strategies that should be considered in this population.Keywords
This publication has 127 references indexed in Scilit:
- Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr−/− miceAnnals of the Rheumatic Diseases, 2012
- Clinical Status and Cardiovascular Risk Profile of Adults with a History of Juvenile DermatomyositisThe Journal of Pediatrics, 2011
- High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipidsAnnals of the Rheumatic Diseases, 2011
- Increased risk of death in pediatric and adult patients with ESRD secondary to lupusPediatric Nephrology, 2010
- B cell depletion reduces the development of atherosclerosis in miceJournal of Experimental Medicine, 2010
- Metabolic Abnormalities and Cardiovascular Risk Factors in Children with MyositisThe Journal of Pediatrics, 2009
- Premature atherosclerosis in pediatric systemic lupus erythematosus: Risk factors for increased carotid intima‐media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohortArthritis & Rheumatism, 2009
- Differences in long‐term disease activity and treatment of adult patients with childhood‐ and adult‐onset systemic lupus erythematosusArthritis Care & Research, 2008
- Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney diseaseNephrology Dialysis Transplantation, 2008
- Predictors of Acquired Lipodystrophy in Juvenile-Onset Dermatomyositis and a Gradient of SeverityMedicine, 2008